The last two-to-three years we have seen Philips complete its transformation into a pure-play healthcare technology vendor. It has reduced its interest in its remaining non-healthcare business Philips Lighting/Signify (now owning only a 16.5% share), made 16 healthcare technology acquisitions since the start of 2017 and organized its internal business units into three core healthcare technology segments, Personal Health, Diagnosis & Treatment and Connected Care. A few weeks ago, several of
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Belong.Life Raises $14M to Expand AI-Powered Social Network for Cancer Patients
Belong.Life, creators of the "Belong - Beating Cancer Together" mobile app, the world's largest social network and navigator app for cancer patients, caregivers and healthcare professionals announced it has raised $14M in Series B funding led by IQVI. The Series B round also included participation from The Group Ventures and other existing investors.Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin after each lost relatives to cancer, Belong - Beating Cancer
Read More
Cedars-Sinai Accelerator Reveals 5th Class of 11 Digital Health Startups
Cedars-Sinai Accelerator, today announced 11 new digital health startups selected to participate in its fifth class from across the United States and Europe. From artificial intelligence to a smart brace for knee replacement patients, these innovative healthcare-focused startups are working to transform health and healthcare delivery as part of the Los Angeles-based accelerator program. Through their innovations, the companies seek to address some of healthcare’s most pressing challenges,
Read More
2019 MedTech Breakthrough Award Category Winners Announced
MedTech Breakthrough, a market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market has unveiled the results of its 2019 MedTech Breakthrough Awards program, showcasing technologies and companies that drive innovation and exemplify the best in medical and health-related technology solutions across the globe.MedTech Breakthrough Awards Program OverviewThe MedTech Breakthrough Awards program is the
Read More
Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas
Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Medically Home Group Nabs $10M for Scalable, Virtual Hospital Platform
Medically Home Group, Inc., a Boston, MA-based technology-enabled services company has raised $10 million in Series B funding led by Cardinal Health and other investors. This strategic investment for Medically Home from Cardinal Health and other investors illustrates the rapid movement in the market for innovative value-based models. The company plans to use the latest round of funding to support scaling efforts and to realize a common vision of enabling cost-effective, patient-centric
Read More
Adventist Integrates CancerIQ Platform with Cerner EHR Systemwide to Get AHEAD of Cancer
Adventist Health is getting AHEAD of hereditary cancer (which tends to be earlier onset, more aggressive, and accounts for 10 percent of all new diagnoses). The Adventist Health Early All-Around Detection – or AHEAD Program – at Adventist Health is a population hereditary cancer risk assessment initiative.To ensure patients in both urban and rural settings have access to the preventive services needed to reduce risk, Adventist Health is partnering with CancerIQ to identify candidates for genetic
Read More
Consumer Awareness of Personalized Medicine Has Only Grown by 1% YoY Since 2013
Consumer awareness of personalized medicine is up 4% from 2018, according to a new report from Dosis, an AI-powered personalized dosing platform. The 2019 Dosis Personalized and Digital Medicine Consumer Report surveyed more than 1,000 consumers, weighted for the U.S. population, to gain a better understanding of how big the disconnect is between the advances in personalized medicine approaches and general consumer awareness of its benefits.Consumer Awareness of Personalized Medicine Continues
Read More
RefleXion Medical Receives $60M Loan for Biology Guiding Radiotherapy Machine
RefleXion Medical, Inc., a biotargeting oncology company developing the first and only biology-guided radiotherapy (BgRT) machine* for targeted cancer treatment has received a $60M senior secured term loan from Oxford Finance LLC. The company plans to use the loan to support the completion of the FDA clearance process for its biology-guided BgRT system and its subsequent commercial launch.
Building from Positron
Emission Tomography
Positron emission tomography (PET) is an established
Read More
Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More
